Intrathalamic implants of GABA-releasing polymer matrices reduce motor impairments in rats with excitotoxically lesioned striata

Experimental Neurology

Volumn 142, Issue 2, 1996, Pages 323-330

  Rozas, G ^a   Liste, I ^a   Lopez Martin, E ^a   Guerra, M J ^a   Kokaia, M ^b   Labandeira Garcia, J L ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE; EXCITOTOXIN; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GABAERGIC SYSTEM; HISTOLOGY; HUNTINGTON CHOREA; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

EID: 0030561118     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0201     Document Type: Article

References (45)

1. 1. ALBIN, R. L., A. B. YOUNG, AND J. B. PENNEY. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12: 366-375.
2. 2. ARBUTHNOTT, G. W., N. K. MACLEOD, D. J. MAXWELL, AND A. K. WRIGHT. 1990. Distribution and synaptic contacts of the cortical terminals arising from neurons in the rat ventromedial thalamic nucleus. Neuroscience 38: 47-60.
3. 3. BERGMAN, H., T. WICHMANN, AND M. R. DELONG. 1990. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436-1438.
4. 4. CARTER, D. A., AND H. C. FIBIGER. 1978. The projections of the entopeduncular nucleus and globus pallidus in rat as demonstrated by autoradiography and horseradish peroxidase histochemistry. J. Comp. Neurol. 177: 113-124.
5. 5. DECKEL, A. W., R. G. ROBINSON, J. T. COYLE, AND P. R. SANBERG. 1983. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington disease by day 18 fetal striatal implants. Eur. J. Pharmacol. 93: 287-288.
6. 6. DELONG, M. R. 1990. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13: 281-285.
7. 7. DENIAU, J. M., AND G. CHEVALIER. 1985. Disinhibition as a basic process in the expression of striatal functions. II. The striatonigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res. 334: 227-233.
8. 8. DEVITO, J. L., AND M. E. ANDERSON. 1982. An autoradiographic study of the efferent connections of the globus pallidus in Macaca mulatta. Exp. Brain Res. 46: 46-107.
9. 9. DUNNET, S. B., AND A. BJÖRKLUND. 1994. Mechanisms of function of neural grafts in the injured brain. In Functional Neural Transplantation (S. B. Dunnett and A. Björklund, Eds.), pp. 531-567. Raven Press, New York.
10. 10. DUNNETT, S. B., O. ISACSON, D. H. S. SIRINATHSINGHJI, D. J. CLARKE, AND A. BJÖRKLUND. 1988. Striatal grafts in rats with unilateral striatal lesions. II. Recovery from dopamine dependent motor asymmetry deficits in skilled paw reaching. Neuroscience 24: 813-820.
11. 11. DUNNETT, S. B., AND S. D. IVERSEN. 1981. Learning impairments following selective kainic acid lesions of the neostriatum. Behav. Brain Res. 2: 189-209.
12. 12. EMERICH, D. F., D. W. CAHILL, AND P. R. SANBERG. 1994. Excitotoxic lesions of the neostriatum as an animal model of Huntington's disease. In Toxin-Induced Models of Neurological Disorders (M. L. Woodruff and A. J. Nonneman, Eds.), pp. 213-257. Plenum, New York.
13. 13. GARCIA-MUÑOZ, M., P. PATINO, A. J. WRIGHT, AND G. W. ARBUTHNOTT. 1983. The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system. Neuroscience 8: 87-95.
14. 14. GERFEN, C. R. 1992. The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15: 285-320.
15. 15. GRAYBIEL, A. M., F. C. LIU, AND S. B. DUNNETT. 1989. Intrastriatal grafts derived from fetal striatal primordial I. Phenotopy and modular organization. J. Neurosci. 9: 3250-3272.
16. 16. GURIDI, J., M. R. LUQUIN, M. T. HERRERO, AND J. A. OBESO. 1993. The subthalamic nucleus: A possible target for stereotaxic surgery in Parkinson's disease. Mov. Disord. 8: 421-429.
17. 17. HERKENHAM, M. 1979. The afferent and efferent connections of the ventromedial thalamic nucleus in the rat. J. Comp. Neurol. 183: 487-518.
18. 18. HOFFMAN, D., L. WAHLBERG, AND P. AEBISCHER. 1990. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110: 39-44.
19. 19. ISACSON, O., P. BRUNDIN, P. A. T. KELLY, F. H. GAGE, AND A. BJÖRKLUND. 1984. Functional neuronal replacement by grafted neurons in the ibotenic acid-lesioned striatum. Nature 311: 458-460.
20. 20. ISACSON, O., S. B. DUNNET, AND A. BJÖRKLUND. 1986. Graft-induced behavioural recovery in an animal model of Huntington disease. Proc. Natl. Acad. Sci. USA 83: 2728-2732.
21. 21. JENNER, P., N. LEIGH, C. D. MARSDEN, AND C. REAVILL. 1979. Dopamine-mediated circling behaviour is modulated by lesions of the ventromedial nucleus of the thalamus. Br. J. Pharmacol. 67: 432.
22. 22. KAMATA, K., T. KAMEYAMA, S. OKUYAMA, S. HASHIMOTO, AND H. AIHARA. 1985. Contralateral circling behavior induced by intranigral microinjections of taurine and GABA in rats. Brain Res. 343: 275-282.
23. 23. KILPATRICK, I. C., M. S. STARR, A. FLETCHER, T. A. JAMES, AND N. K. MACLEOD. 1980. Evidence for a GABAergic nigrothalamic pathway in the rat. Exp. Brain Res. 40: 45-54.
24. 24. KITA, H., AND S. T. KITAI. 1988. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations. Brain Res. 447: 346-352.
25. 25. KOKAIA, M., P. AEBISCHER, E. ELMER, J. BENGZON, P. KALEN, Z. KOKAIA, AND O. LINDVALL. 1994. Seizure suppression in kindling epilepsy by intracerebral implants of GABA-but not by noradrenaline-releasing polymer matrices. Exp. Brain Res. 100: 385-394.
26. 26. KOWALL, N. W., R. J. FERRANTE, AND J. B. MARTIN. 1987. Patterns of cell loss in Huntington's disease. Trends Neurosci. 10: 24-29.
27. 27. LABANDEIRA-GARCIA, J. L., AND M. J. GUERRA. 1994. Cortical stimulation induces fos expression in intrastriatal striatal grafts. Brain Res. 652: 87-97.
28. 28. LABANDEIRA-GARCIA, J. L., K. WICTORIN, E. T. CUNNINGHAM, AND A. BJÖRKLUND. 1991. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience 42: 407-426.
29. 29. LABANDEIRA-GARCIA, J. L., I. LISTE, J. P. TOBIO, G. ROZAS, E. LOPEZ-MARTIN, AND M. J. GUERRA. 1995. Intrathalamic striatal grafts survive and affect circling behaviour in adult rats with excitotoxically lesioned striatum. Neuroscience 68: 737-749.
30. 30. LINDVALL, O. 1991. Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci. 14: 376-388.
31. 31. MCRAE, A., E. A. LING, S. HJORTH, A. DAHLSTRÖM, D. MASON, AND T. TICE. 1994. Catecholamine-containing biodegradable microsphere implants as a novel approach in treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. Mol. Neurobiol. 9: 191-205.
32. 32. MALOTEAUX, J., J. OCTAVE, A. GOSSUIN, C. LATERRE, AND A. TROUET. 1987. GABA induces down regulation of the benzodiazepine-GABA receptor complex in the rat cultured neurons. Eur. J. Pharmacol. 144: 173-183.
33. 33. PAGE, R. D. 1992. The use of thalamotomy in the treatment of levodopa-induced dyskinesia. Acta Neurochir. (Wien) 114: 77-117.
34. 34. PAGE, R. D., M. A. SAMBROOK, AND A. R. CROSSMAN. 1993. Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 55: 147-165.
35. 35. PARENT, A., AND L. HAZRATI. 1995. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20: 91-127.
36. 36. PASINETTI, G. M., D. G. MORGAN, AND C. E. FINCH. 1991. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following strial ibotenic acid lesions: Evidence for transneuronal regression. Exp. Neurol. 112: 131-139.
37. 37. PESCHANSKI, M., P. CESARO, AND P. HANTRAYES. 1995. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68: 273-285.
38. 38. SAJI, M., AND D. J. REIS. 1987. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science 235: 66-69.
39. 39. SIGNORE, A. P., M. GODDARD, P. A. TRESCO, R. BURRILL, AND P. AEBISCHER. 1993. GABA delivery to the subthalamic nucleus alleviates MPTP induced hemiparkinsonism in non-human primates. Soc. Neurosci. Abstr. 19: 428.9.
40. 40. SOTO-OTERO, R., E. MENDEZ-ALVAREZ, J. GALAN-VALIENTE, E. AGUILAR-VEIGA, AND G. SIERRA-MARCUÑO. 1994. Quantitative analysis of neuroactive amino acids in brain tissue by liquid chromatography using fluorescent pre-column labelling with o-phthaldehyde and JV-acetyl-L-cysteine. Biomed. Chromatogr. 8: 114-118.
41. 41. STARR, M. S., AND M. SUMMERHAYES. 1983. Role of the ventromedial nucleus of the thalamus in motor behaviour-II. Effects of lesions. Neuroscience 10: 1171-1183.
42. 42. STARR, M. S., AND M. SUMMERHAYES. 1983. Role of the ventromedial nucleus of the thalamus in motor behaviour. I. Effects of focal injections of drugs. Neuroscience 10: 1157-1169.
43. 43. WICTORIN, K., AND A. BJORKLUND. 1989. Connectivity of striatal grafts implanted into ibotenic acid lesioned striatum. II. Cortical afferents. Neuroscience 30: 297-311.
44. 44. WICTORIN, K., C. C. OUIMET, AND A. BJÖRKLUND. 1989. Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry: Specificity of connections with the lesioned host brain. Eur. J. Neurosci. 1: 690-701.
45. 45. WINN, S. R., L. WAHLBERG, P. A. TRESCO, AND P. AEBISCHER. 1989. An encapsulated dopamine-releasing polymer alliviates experimental Parkinsonism in rats. Exp. Neurol. 105: 244-250.